首页|银杏达莫注射液联合丁苯酞治疗急性脑梗死的临床效果

银杏达莫注射液联合丁苯酞治疗急性脑梗死的临床效果

扫码查看
目的 探讨急性脑梗死(ACI)患者采用银杏达莫注射液联合丁苯酞治疗的临床效果。方法 选取 2021 年 11月至 2022 年 3 月在稷山县人民医院接受治疗的ACI患者共计 92 例,以随机数表法分为对照组与研究组,各 46 例,对照组给予丁苯酞治疗,研究组给予银杏达莫注射液联合丁苯酞治疗,对两组临床疗效、神经功能缺损、血流速度指标、血液流变学指标、功能恢复结局、不良反应进行比较。结果 研究组治疗有效率(95。65%)较对照组(80。43%)更高,差异有统计学意义(P<0。05);两组治疗后与同组治疗前相比,美国国立卫生院神经功能缺损评分(NIHSS)均降低,且研究组较对照组更低,差异有统计学意义(P<0。05);两组治疗后与同组治疗前相比,舒张末期血流速度(Vd)、平均血流速度(Vm)、收缩期峰值血流速度(Vs)均加快,研究组较对照组更快,差异有统计学意义(P<0。05);两组治疗后与同组治疗前相比,血浆粘度(PSV)、全血高切粘度(HSV)、纤维蛋白原(FIB)降低,研究组较对照组更低,差异有统计学意义(P<0。05);随访 6 个月与同组治疗前,两组改良Rankin量表(mRS)评分降低,研究组较对照组更低(P<0。05),差异均有统计学意义;研究组不良反应发生率(4。35%)较对照组(23。91%)更低,差异有统计学意义(P<0。05)。结论 ACI患者采用银杏达莫注射液联合丁苯酞治疗,能够促进临床疗效提升,改善神经功能、血流速度,促进血液流变学指标改善,减少不良反应发生。
Clinical Effect of Ginkgo Leaf Extract and Dipyridamole Injection Combined with Butylphthalide in the Treatment of Acute Cerebral Infarction
Objective To investigate the clinical effect of ginkgo leaf extract and dipyridamole injection combined with butylphthalide in the treatment of acute cerebral infarction(ACI).Methods A total of 92 ACI patients treated in Jishan County People's Hospital from November 2021 to March 2022 were selected and divided into control groups and study groups by random number table method,with 46 cases in each group.The control group was treated with butylphthalide,and the study group was treated with ginkgo leaf extract and dipyridamole injection combined with butylphthalide.The clinical efficacy,neurological impairment,blood flow velocity index,hemorheology index,functional recovery outcome,and adverse reactions were compared between the two groups.Results The effective rate of the study group(95.65%)was higher than that of the control group(80.43%),the difference was statistically significant(P<0.05).The National Institutes of Health Neurological Impairment Score(NIHSS)was lower in both groups after treatment than before treatment,and the difference was statistically significant(P<0.05).After treatment,the end-diastolic blood flow velocity(Vd),mean blood flow velocity(Vm),and peak systolic blood flow velocity(Vs)of the two groups were accelerated compared with those before treatment,and the study group was faster than the control group,the difference was statistically significant(P<0.05);After treatment,the plasma viscosity(PSV),whole blood high shear viscosity(HSV)and fibrinogen(FIB)of the two groups were lower than those of the control group,and the difference was statistically significant(P<0.05).After 6 months of follow-up,the modified Rankin Scale(mRS)score of the two groups was lower than that of the control group(P<0.05),and the difference was statistically significant.The incidence of adverse reactions in the study group(4.35%)was lower than that in the control group(23.91%),the difference was statistically significant(P<0.05).Conclusion Ginkgo leaf extract and dipyridamole injection combined with butylphthalide in the treatment of ACI patients can promote clinical efficacy,improve neurological function,and blood flow velocity,promote the improvement of hemorheological indicators,and reduce the occurrence of adverse reactions.

ginkgo leaf extract and dipyridamole injectionbutylphthalideacute cerebral infarctionneurological function

兰洁

展开 >

稷山县人民医院 神经内科,山西 运城 043200

银杏达莫注射液 丁苯酞 急性脑梗死 神经功能

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(1)
  • 18